Product category:
Pharmaceutical Processing News
News Release from: Amersin Life Sciences
Edited by the Processingtalk Editorial
Team on 17 January 2005
Amersin Life Sciences Corporation is
born
Amersin Life Sciences Corporation announces a new trading symbol and the completion of name change from the Hubei Pharmaceutical Group.
Amersin Life Sciences advises that it has completed its name change and been assigned a new trading symbol and CUSIP number Effective at the opening of markets on January 14th, 2004 the new trading symbol for Amersin Life Sciences Corporation in the United States will be AMLS
This article was originally published on Processingtalk on 9 Jul 2003 at 8.00am (UK)
Related stories
Robot army for Land Rover
ABB, the global power and automation technologies group, announced today that it has won an order from Ford Premier Automotive Group to supply 186 industrial robots to Land Rover
ABB creates new Nationwide instrumentation network
A new comprehensive instrumentation supply and service network has been created by ABB to serve customers throughout the UK: the Instrumentation Alliance comprises five carefully selected partners
The new CUSIP number is 03075R104.
Amersin Life Sciences Corporation is engaged in the acquisition and vertical integration of operating subsidiaries and controlling joint venture interests in China to include all facets of pharmaceutical life sciences from raw materials through dosage form production and distribution.
The company owns a controlling interest in a profitable pharmaceutical factory, Hubei Tongji Benda Ebei Pharmaceutical Co located in Guangshui City, Hubei Province, China.
Further reading
Technical services agreement with Serbian Oil
AMEC has taken an important first step towards becoming a leading energy service provider in the Balkan region with the winning of a multi-million pound Gasoline Improvement Project in northern Serbia
80% growth for robotics and semiconductor supplier
With the Max 3000 series range of compact distributed motion controllers and multiple axis amplifiers, Agile was able to post an 80% increase in 2002 product shipments over previous 12 months
It is a continuation and expansion of the dosage division previously owned by Hubei Benda Science and Technology Co whose management and controlling partners hold a minority interest and provide ongoing operational management.
This is characteristic of our acquisition strategy, providing continuity of the successful management team and other resources while looking for opportunities to streamline operations and broaden market penetration through strategic relationships with other subsidiaries or independent organizations in the life sciences field.
Our business plan positions Amersin as a holding company, providing investment capital and a western perspective on the development of brand and market share.
We act as a catalyst in identifying pharmaceutical enterprises as acquisition targets to build and integrate their areas of specialisation into a synergetic whole that exceeds the achievements of the individual operating units.
We are focused on building investor equity through strategic acquisition and vertical integration.
"The name change is an important step forward in our corporate development, more closely reflecting the goals and diversity of our business plan" commented Howard Milne, director of corporate communications.
"It more clearly differentiates the US holding company and its western management style from the operating subsidiaries in China.
Completion paves the way to broaden our investor relations activities, drawing attention to our successful track record and consistent quarterly profits, paving the way for future expansion and illustrating what we believe will be seen as an attractive, early stage opportunity to participate in the pharmaceutical life sciences sector in the booming Chinese economy".
• Amersin Life Sciences: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
